Michiganders who are eligible to receive a COVID-19 vaccine booster dose are urged to do so now.

Michiganders who are eligible to receive a COVID-19 vaccine booster dose from Johnson & Johnson or Moderna are urged to do so now.

The Food and Drug Administration released the following statement Friday, Sept. 10, 2021 as COVID-19 makers are racing to submit clinical data seeking regulatory approval for vaccines in children younger than 12.

Portugal is beginning its journey to what the country’s prime minister calls “total freedom.”.

University of Michigan announces it will switch some Johnson & Johnson COVID-19 vaccine clinics to Pfizer, cancels others.

South Africa has suspended giving the Johnson & Johnson vaccine as a “precautionary measure” following the FDA decision in the United States to pause the use of the vaccine while very rare blood clot cases are examined.

This Sept. 2020 photo provided by Johnson & Johnson shows a scientist in Janssen laboratory in Leiden, The Netherlands. Johnson & Johnson said Friday, Jan. 29, 2021 that in the U.S. and seven other countries, the first single-shot vaccine appears 66% effective overall at preventing moderate to severe COVID-19. More: Henry Ford to carry out phase 3 of COVID-19 vaccine trial in Metro DetroitThat trial showed that the single-shot version of the vaccine was 85% effective overall in preventing severe disease and complete protection against COVID-19 related hospitalization and death. It was 65% effective overall in preventing moderate to severe COVID-19. Anyone interested in volunteering may sign up at this link on the Henry Ford website.

This Sept. 2020 photo provided by Johnson & Johnson shows a scientist in Janssen laboratory in Leiden, The Netherlands. (Johnson & Johnson via AP)Here’s what’s happening Friday with the coronavirus pandemic in the U.S.:THREE THINGS TO KNOW TODAY:— Johnson & Johnson says its vaccine appears to protect against COVID-19 with just one shot. The vaccine worked better in the U.S. compared to South Africa, where it was up against a tougher, mutated virus. ICYMI: The role that race should play in deciding who gets priority for the COVID-19 vaccine has been put to the test in Oregon. City officials made an unusual choice when they picked a 22-year-old graduate student to run a large vaccination site.

ANN ARBOR – Michigan Medicine and Janssen, a division of Johnson & Johnson, are now recruiting for a double-blind phase III COVID-19 vaccine clinical trial. Known as the ENSEMBLE study, the trial will test an investigational vaccine to prevent COVID-19. The University of Michigan is one of several test sites around the globe supporting the trial, which aims to enroll up to 60,000 volunteers. “Michigan Medicine is committed to supporting the continued study of the investigational Janssen vaccine and other vaccine candidates. The Janssen study is the second COVID-19 trial to be recruiting at U-M, along with the AstraZeneca trial.